Valuation: Sanofi

Market Cap 92.46B 3,550B 105B 85.46B 78.6B 148B 10,172B 151B 1,022B 401B 4,977B 396B 387B 17,147B P/E 2026 *
11.6x
P/E 2027 * 10.7x
Enterprise Value 102B 3,920B 116B 94.36B 86.79B 164B 11,232B 166B 1,128B 442B 5,495B 437B 428B 18,933B EV / Sales 2026 *
2.18x
EV / Sales 2027 * 1.96x
Free-Float
89%
Yield 2026 *
5.53%
Yield 2027 * 5.86%
1 day+0.68%
1 week+1.37%
Current month+4.23%
1 month+5.71%
3 months-3.90%
6 months+2.78%
Current year-3.90%
1 week 2.88
Extreme 2.88
3
1 month 2.7
Extreme 2.7
3
Current year 2.7
Extreme 2.7
3.18
1 year 2.7
Extreme 2.7
3.44
3 years 2.7
Extreme 2.7
4.1
5 years 2.7
Extreme 2.7
4.1
10 years 2.7
Extreme 2.7
4.1
Manager TitleAgeSince
Chief Executive Officer 65 01/05/2026
Director of Finance/CFO 64 01/04/2024
Chief Tech/Sci/R&D Officer 51 11/09/2023
Director TitleAgeSince
Director/Board Member 60 30/04/2019
Director/Board Member 57 28/04/2020
Director/Board Member 64 28/04/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.68%+1.37% - - 105B
-2.73%-2.96%+48.62%+147.27% 1,023B
-1.67%-3.47%+52.00%+47.77% 599B
-0.44%+2.17%+33.88%+78.20% 448B
-0.18%+1.31%+29.62%+20.65% 326B
+2.84%+3.46%+38.35%+38.78% 278B
+0.54%+0.70%+21.69%+15.61% 258B
-0.95%+1.81%-20.78%-41.31% 222B
-0.58%+1.03%+23.55%+56.14% 197B
-0.80%+1.38%+23.09%+66.64% 165B
Average +0.25%-0.38%+27.78%+47.75% 390.56B
Weighted average by Cap. +0.32%-1.18%+35.79%+70.75%

Financials

2026 *2027 *
Net sales 46.94B 1,802B 53.55B 43.38B 39.9B 75.29B 5,164B 76.49B 519B 203B 2,527B 201B 197B 8,705B 50.02B 1,921B 57.07B 46.23B 42.52B 80.23B 5,503B 81.52B 553B 217B 2,693B 214B 210B 9,277B
Net income 8.33B 320B 9.5B 7.7B 7.08B 13.36B 916B 13.57B 92.03B 36.07B 448B 35.67B 34.89B 1,544B 9.22B 354B 10.52B 8.53B 7.84B 14.8B 1,015B 15.03B 102B 39.97B 497B 39.52B 38.66B 1,711B
Net Debt 9.63B 370B 10.99B 8.9B 8.19B 15.45B 1,060B 15.7B 106B 41.73B 518B 41.26B 40.36B 1,786B 5.52B 212B 6.3B 5.1B 4.69B 8.85B 607B 9B 61B 23.91B 297B 23.65B 23.13B 1,024B
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases; - human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2025, the group had 37 production sites worldwide. Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).
Employees
74,846
Date Price Change Volume
20/07/26 THB 2.960 +0.68% 153,013
17/07/26 THB 2.940 -0.68% 163,462
16/07/26 THB 2.960 +2.78% 33,208
15/07/26 THB 2.880 -0.69% 21,754
14/07/26 THB 2.900 -0.68% 12,258
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
76.91EUR
Average target price
96.31EUR
Spread / Average Target
+25.23%

Quarterly revenue - Rate of surprise